Correction of Hunter Syndrome in the MPSII Mouse Model by AAV2/8-Mediated Gene Delivery

被引：0
|
作者：
Cardone, Monica
Polito, Vinicia Assunta
Pepe, Stefano
Mann, Linda
D'Azzo, Alessandra
Auricchio, Alberto
Ballabio, Andrea
Cosma, Maria Pia
机构：
[1] TIGEM Telethon Inst Genet & Med, Naples, Italy
[2] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.234
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
209
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [1] Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery
    Cardone, M
    Polito, VA
    Pepe, S
    Mann, L
    D'Azzo, A
    Auricchio, A
    Ballabio, A
    Cosma, MP
    HUMAN MOLECULAR GENETICS, 2006, 15 (07) : 1225 - 1236
  • [2] AAV2/8-Mediated delivery to the juvenile mouse liver
    Cunningham, S. C.
    Dane, A. P.
    Spinoulas, A.
    Alexander, I. E.
    JOURNAL OF GENE MEDICINE, 2007, 9 (06): : 527 - 527
  • [3] AAV2/8-Mediated correction of OTC deficiency in the adult and neonatal spfash mouse
    Cunningham, S. C.
    Spinoulas, A.
    Dane, A. P.
    Carpenter, K.
    Wilcken, B.
    Kuchell, P.
    Alexander, I. E.
    JOURNAL OF GENE MEDICINE, 2007, 9 (06): : 527 - 528
  • [4] AAV2/8-mediated Correction of OTC Deficiency Is Robust in Adult but Not Neonatal Spfash Mice
    Cunningham, Sharon C.
    Spinoulas, Afroditi
    Carpenter, Kevin H.
    Wilcken, Bridget
    Kuchel, Philip W.
    Alexander, Ian E.
    MOLECULAR THERAPY, 2009, 17 (08) : 1340 - 1346
  • [5] Gene delivery to the juvenile mouse liver using AAV2/8 vectors
    Cunningham, Sharon C.
    Dane, Allison P.
    Spinoulas, Afroditi
    Alexander, Ian E.
    MOLECULAR THERAPY, 2008, 16 (06) : 1081 - 1088
  • [6] Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy
    Wang, LL
    Calcedo, R
    Nichols, TC
    Bellinger, DA
    Dillow, A
    Verma, IM
    Wilson, JM
    BLOOD, 2005, 105 (08) : 3079 - 3086
  • [7] Long-term correction of hyperphenylalaninemia following liver-directed, AAV2/8-mediated gene therapy in murine phenylketonuria
    Harding, C. O.
    Gillingham, M. B.
    Bird, A.
    Koeberl, D. D.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 30 - 30
  • [8] Safety of Liver-Directed AAV2/8-Mediated Gene Transfer in a Large Animal Model of Lysosomal Storage Disease
    Ferla, Rita
    Haskins, Mark
    Auricchio, Alberto
    MOLECULAR THERAPY, 2012, 20 : S55 - S55
  • [9] Improved therapeutic efficacy following AAV2/8-mediated expression of α-galactosidase A in Fabry mice
    Ziegler, RJ
    Barbon, CM
    Li, C
    Bercury, S
    Cherry, M
    Cheng, SH
    MOLECULAR THERAPY, 2004, 9 : S263 - S263
  • [10] AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma
    Harding, Thomas C.
    Lalani, Alshad S.
    Roberts, Byron N.
    Yendluri, Satya
    Luan, Bo
    Koprivnikar, Kathryn E.
    Gonzalez-Edick, Melissa
    Guang Huan-Tu
    Musterer, Randy
    VanRoey, Melinda J.
    Ozawa, Tomoko
    LeCouter, Richard A.
    Deen, Dennis
    Dickinson, Peter J.
    Jooss, Karin
    MOLECULAR THERAPY, 2006, 13 (05) : 956 - 966
12345